Hengrui Medicine Sets Up Wholly-Owned Subsidiary with RMB 50 Million Investment
Hengrui Medicine has established a wholly-owned subsidiary, Zhejiang Hengrui Medicine Co. , Ltd. , with a registered capital of RMB 50 million. The new entity, with legal representative Dai Hongbin, will engage in medical research, drug wholesale, retail, and entrusted production. Hengrui Medicine holds 100% ownership of the subsidiary.
Hengrui Medicine has established a new wholly-owned subsidiary with a registered capital of RMB 50 million. According to corporate registration information, Zhejiang Hengrui Medicine Co. , Ltd. was recently incorporated, with Dai Hongbin serving as its legal representative. The company's business scope covers medical research and experimental development, drug wholesale, drug retail, and entrusted drug production. The equity structure shows that Hengrui Medicine holds 100% of the subsidiary's shares.